Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017-2025

Mar 2018| TMR313A| Transparency

Report Highlights

Global MRSA Drugs Market: Overview

This report on the Global Methicillin-resistant Staphylococcus Aureus (MRSA) Drugs Market analyzes the current and future scenario of the global market. Rise in private and public funding for R&D of novel anti-MRSA drug molecules, increase in prevalence of MRSA infections, and their improved screening are boosting the growth of the global MRSA drugs market. According to CDC, two in every 100 people carry MRSA. Introduction of generic drugs for the MRSA treatment, and upsurge in the consumption of antibiotics in the developing countries are some of the factors expected to drive the growth of global MRSA drugs market during the forecast period.

The MRSA drugs market report comprises an elaborate executive summary, which includes market snapshot that provides information about various segments. It also provides information and data analysis of the global market with respect to the segments based on drug class, route of administration, distribution channel, and geography. A detailed qualitative analysis of drivers and restraints, and opportunities has been provided in the market overview section. Additionally, the report comprises epidemiological assessment of MRSA infection, in terms of causes, complications, current & future treatment options for MRSA, along with its prevalence rate in key countries. The report contains comparative analysis of key companies operating in the global MRSA drugs market, in terms of strategic developments, current and future market positioning, and their key differential parameters, to help understand the competitive landscape in the market. Moreover, the global corporate scenario is provided in the report with major pipeline products of emerging and established pharmaceutical manufacturers, and their respective dosage forms. This report also provides market attractiveness and its analysis in terms of geography and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global MRSA drugs market.

Global MRSA Drugs Market: Key Segments

Based on the drug class, the global MRSA drugs market is segmented into lipopeptide, oxazolidinone, cephalosporin, tetracycline, lipoglycopeptide, folate antagonist, and others. Lipopeptide accounted for highest market share in 2016, owing to the diversified distribution of daptomycin (lipopeptide) across the globe by key distributors in 2016. Others drug class is projected to expand at relatively significant CAGR during 2017-2025, which is attributable to the rising incidence of community-acquired MRSA infection. Different types of route of administration in the MRSA drugs market are oral and parenteral. Parenteral segment dominated the market in terms of market share in 2016, and is expected to continue to lead the global market during forecast period. However, oral segment is likely to expand during 2017-2025, due to presence of numerous oral vaccines against MRSA infection in the developmental phase by key companies. Various distribution channels in the global MRSA market are hospital pharmacy, retail pharmacy, and online pharmacy. Hospital pharmacy held maximum market share in 2016, and is expected to remain dominant by 2025 in terms of revenue. However, online pharmacy is likely to expand with maximum CAGR owing to the rising adoption of the population for digital platform. The market size and forecast for each of these segments have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year.

Global MRSA Drugs Market: Regional Outlook

Geographically, the global MRSA drugs has been categorized into five major regions and the key countries in the respective region: North America (U.S. and Canada), Europe (U.K., Germany, France, Spain, Italy, Russia, and Rest of Europe), Asia Pacific (India, China, Japan, Australia & New Zealand, and Rest of Asia Pacific), Latin America (Brazil, Mexico, and Rest of Latin America) and Middle East & Africa (South Africa, GCC Countries, Israel, and Rest of Middle East & Africa). The market size and forecast for each of these regions and the mentioned countries have been provided for the period from 2015 to 2025, along with their respective CAGRs for the forecast period from 2017 to 2025, considering 2016 as the base year. The research study also covers the competitive scenario in these regions.

Companies Mentioned in Report

The report also profiles major players in the global MRSA drugs based on various attributes such as company overview, financial overview, product portfolio, business strategies, SWOT analysis, and recent developments. Major players profiled in this report include Basilea Pharmaceutica Ltd., The Medicines Company, Theravance Biopharma, Allergan, Merck & Co., Inc., and Pfizer, Inc.

The Global MRSA drugs Market has been segmented as given below:

Global MRSA Drugs Market, by Drug Class

Lipopeptide
Oxazolidinone
Tetracycline
Cephalosporin
Lipoglycopeptide
Folate Antagonist
Others

Global MRSA Drugs Market, by Route of Administration

Oral
Parenteral

Global MRSA Drugs Market, by Distribution Channel

Hospital Pharmacy
Retail Pharmacy
Online Pharmacy

Global MRSA drugs Market, by Region

North America
U.S.
Canada
Europe
Germany
U.K.
France
Italy
Spain
Rest of Europe
Asia Pacific
India
China
Japan
Rest of Asia Pacific
Latin America
Brazil
Mexico
Rest of Latin America
Middle East & Africa
GCC Countries
South Africa
Israel
Rest of Middle East & Africa

  • Table 1 : Global MRSA infection Prevalence (%), 2015
  • Table 2 : Global MRSA infection Prevalence (%), 2015
  • Table 3 : Global MRSA infection Prevalence (%), 2015
  • Table 4 : MRSA Drugs: Pipeline Snapshot, 2016
  • Table 5 : MRSA Drugs: Pipeline Snapshot, 2016
  • Table 6 : MRSA Drugs: Competitive Landscape
  • Table 7 : Global MRSA Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 8 : Global MRSA Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 9 : Global MRSA Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 10 : Global MRSA Drugs Market Size (US$ Mn) Forecast, by Region, 2015–2025
  • Table 11 : North America MRSA Drugs Market Size (US$ Mn) Forecast, by Country, 2015–2025
  • Table 12 : North America MRSA Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 13 : North America MRSA Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 14 : North America MRSA Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 15 : Europe MRSA Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 16 : Europe MRSA Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 17 : Europe MRSA Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 18 : Europe MRSA Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 19 : Asia Pacific MRSA Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 20 : Asia Pacific MRSA Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 21 : Asia Pacific MRSA Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 22 : Asia Pacific MRSA Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 23 : Latin America MRSA Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 24 : Latin America MRSA Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 25 : Latin America MRSA Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 26 : Latin America MRSA Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Table 27 : Middle East & Africa MRSA Drugs Market Size (US$ Mn) Forecast, by Country/Sub-region, 2015–2025
  • Table 28 : Middle East & Africa MRSA Drugs Market Size (US$ Mn) Forecast, by Drug Class, 2015–2025
  • Table 29 : Middle East & Africa MRSA Drugs Market Size (US$ Mn) Forecast, by Route of Administration, 2015–2025
  • Table 30 : Middle East & Africa MRSA Drugs Market Size (US$ Mn) Forecast, by Distribution Channel, 2015–2025
  • Figure 1 : Global MRSA Drugs Market Size (US$ Mn) and Distribution (%) by Geography, 2017 and 2025
  • Figure 2 : Global MRSA Drugs Market Value Share, by Drug Class (2016)
  • Figure 3 : Global MRSA Drugs Market Value Share, by Route of Administration (2016)
  • Figure 4 : Global MRSA Drugs Market Value Share, by Distribution Channel (2016)
  • Figure 5 : Global MRSA Drugs Market Value Share, by Region (2016)
  • Figure 6 : Key Manufacturers: Comparison Analysis
  • Figure 7 : Global MRSA Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 8 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lipopeptide, 2015–2025
  • Figure 9 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Oxazolidinone, 2015–2025
  • Figure 10 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cephalosporin, 2015–2025
  • Figure 11 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Tetracycline, 2015–2025
  • Figure 12 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Folate Antagonist, 2015–2025
  • Figure 13 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Drug Classes, 2015–2025
  • Figure 14 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Lipoglycopeptide, 2015–2025
  • Figure 15 : Global MRSA Drugs Market Attractiveness, by Drug Class, 2017–2025
  • Figure 16 : Global MRSA Drugs Market Value Share, by Route of Administration, 2017 and 2025
  • Figure 17 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Oral Route of Administration, 2015–2025
  • Figure 18 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Parenteral Route of Administration, 2015–2025
  • Figure 19 : Global MRSA Drugs Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 20 : Global MRSA Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 21 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospital Pharmacy, 2015–2025
  • Figure 22 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Retail Pharmacy, 2015–2025
  • Figure 23 : Global MRSA Drugs Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Online Pharmacy, 2015–2025
  • Figure 24 : Global MRSA Drugs Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 25 : Global MRSA Drugs Market Value Share, by Region, 2017 and 2025
  • Figure 26 : Global MRSA Drugs Market Attractiveness, by Region, 2017–2025
  • Figure 27 : North America MRSA Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
  • Figure 28 : North MRSA Drugs Market Attractiveness, by Country, 2017–2025
  • Figure 29 : North America MRSA Drugs Market Value Share, by Country, 2017 and 2025
  • Figure 30 : North America MRSA Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 31 : North America MRSA Drugs Market Attractiveness, by Drug Class, 2017–2025
  • Figure 32 : North America MRSA Drugs Market Value Share, by Route of Administration, 2017 and 2025
  • Figure 33 : North America MRSA Drugs Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 34 : North America MRSA Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 35 : North America MRSA Drugs Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 36 : Europe MRSA Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
  • Figure 37 : Europe MRSA Drugs Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 38 : Europe MRSA Drugs Market Value Share, by Country/Sub-region, 2017 and 2025
  • Figure 39 : Europe MRSA Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 40 : Europe MRSA Drugs Market Attractiveness, by Drug Class, 2017–2025
  • Figure 41 : Europe MRSA Drugs Market Value Share, by Route of Administration, 2017 and 2025
  • Figure 42 : Europe MRSA Drugs Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 43 : Europe MRSA Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 44 : Europe MRSA Drugs Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 45 : Asia Pacific MRSA Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
  • Figure 46 : Asia Pacific MRSA Drugs Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 47 : Asia Pacific MRSA Drugs Market Value Share, by Country/Sub-region, 2017 and 2025
  • Figure 48 : Asia Pacific MRSA Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 49 : Asia Pacific MRSA Drugs Market Attractiveness, by Drug Class, 2017–2025
  • Figure 50 : Asia Pacific MRSA Drugs Market Value Share, by Route of Administration, 2017 and 2025
  • Figure 51 : Asia Pacific MRSA Drugs Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 52 : Asia Pacific MRSA Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 53 : Asia Pacific MRSA Drugs Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 54 : Latin America MRSA Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
  • Figure 55 : Latin America MRSA Drugs Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 56 : Latin America MRSA Drugs Market Value Share, by Country/Sub-region, 2017 and 2025
  • Figure 57 : Latin America MRSA Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 58 : Latin America MRSA Drugs Market Attractiveness, by Drug Class, 2017–2025
  • Figure 59 : Latin America MRSA Drugs Market Value Share, by Route of Administration, 2017 and 2025
  • Figure 60 : Latin America MRSA Drugs Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 61 : Latin America MRSA Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 62 : Latin America MRSA Drugs Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 63 : Middle East & Africa MRSA Drugs Market Size (US$ Mn) Forecast and Y-o-Y Growth Projection (%), 2015–2025
  • Figure 64 : Middle East & Africa MRSA Drugs Market Attractiveness, by Country/Sub-region, 2017–2025
  • Figure 65 : Middle East & Africa MRSA Drugs Market Value Share, by Country/Sub-region, 2017 and 2025
  • Figure 66 : Middle East & Africa MRSA Drugs Market Value Share, by Drug Class, 2017 and 2025
  • Figure 67 : Middle East & Africa MRSA Drugs Market Attractiveness, by Drug Class, 2017–2025
  • Figure 68 : Middle East & Africa MRSA Drugs Market Value Share, by Route of Administration, 2017 and 2025
  • Figure 69 : Middle East & Africa MRSA Drugs Market Attractiveness, by Route of Administration, 2017–2025
  • Figure 70 : Middle East & Africa MRSA Drugs Market Value Share, by Distribution Channel, 2017 and 2025
  • Figure 71 : Middle East & Africa MRSA Drugs Market Attractiveness, by Distribution Channel, 2017–2025
  • Figure 72 : Global MRSA Drugs Market Share, by Company, 2016

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us